Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
BCRI - Clinical Trials
PDF) CHAMPION PHOENIX Trial
PPT - CHAMPION PHOENIX PowerPoint Presentation, free download - ID:2257235
Table 1 from Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention | Semantic Scholar
Consistent Reduction in MI with Cangrelor Deepak L - ppt download
The Effect of Cangrelor and Access Site on Ischemic and Bleeding Events – Insights from CHAMPION PHOENIX J. Antonio Gutierrez, MD, MHS, Robert A. Harrington, - ppt download
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention
CHAMPION PHOENIX: Effect of Cangrelor and Access Site on Ischemic and Bleeding Events | tctmd.com
Table 5 from Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use | Semantic Scholar
PPT - CHAMPION PHOENIX PowerPoint Presentation, free download - ID:2257235
Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX | tctmd.com
CHAMPION PHOENIX IPST: Implications of Intraprocedural Stent Thrombosis During PCI from a Prospective, Randomized Trial of a Potent Intravenous ADP Antagonist vs. a Standard Ora... | tctmd.com
Subanalyses of the CHAMPION PHOENIX trial. | Download Scientific Diagram
60104-8.fp.png "THE EFFICACY, SAFETY, AND NET CLINICAL BENEFIT OF CANGRELOR IN WOMEN UNDERGOING ELECTIVE OR URGENT PCI: INSIGHTS FROM THE CHAMPION-PHOENIX TRIAL | Journal of the American College of Cardiology")
THE EFFICACY, SAFETY, AND NET CLINICAL BENEFIT OF CANGRELOR IN WOMEN UNDERGOING ELECTIVE OR URGENT PCI: INSIGHTS FROM THE CHAMPION-PHOENIX TRIAL | Journal of the American College of Cardiology
Cangrelor Superior to Clopidogrel in CHAMPION PHOENIX Trial | DAIC
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events | NEJM
Hallway Buzz: CHAMPION PHOENIX Trial with Deepak Bhatt, MD | MedPageToday
Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial | Journal of the American College of Cardiology
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events | NEJM
Efficacy outcomes at 30 days in CHAMPION-PHOENIX trial. | Download Table
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention | JACC: Cardiovascular Interventions
CHAMPION-PHOENIX (IV Cangrelor vs Oral Clopidogrel for the Management of Periprocedural PCI Complications)
